Metagenomi (MGX) Equity Average (2023 - 2025)
Historic Equity Average for Metagenomi (MGX) over the last 3 years, with Q3 2025 value amounting to $187.1 million.
- Metagenomi's Equity Average fell 2873.5% to $187.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $187.1 million, marking a year-over-year decrease of 2873.5%. This contributed to the annual value of $49.6 million for FY2024, which is N/A changed from last year.
- According to the latest figures from Q3 2025, Metagenomi's Equity Average is $187.1 million, which was down 2873.5% from $204.2 million recorded in Q2 2025.
- Metagenomi's Equity Average's 5-year high stood at $272.5 million during Q2 2024, with a 5-year trough of -$96.3 million in Q2 2023.
- Over the past 3 years, Metagenomi's median Equity Average value was $195.7 million (recorded in 2025), while the average stood at $125.0 million.
- Per our database at Business Quant, Metagenomi's Equity Average surged by 61159.37% in 2024 and then crashed by 2873.5% in 2025.
- Quarter analysis of 3 years shows Metagenomi's Equity Average stood at -$67.9 million in 2023, then soared by 461.55% to $245.3 million in 2024, then decreased by 23.71% to $187.1 million in 2025.
- Its last three reported values are $187.1 million in Q3 2025, $204.2 million for Q2 2025, and $223.8 million during Q1 2025.